B2IMY5 AF NFT

tRNA dimethylallyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibm7zxuadanb66x2csfzlmz6srhro3goibabcdbwwozo536zrt6cy/metadata.json
IPFS of structure file: 
bafybeic6wlmx5ge36v4n64mxnkgpwjgddzkba6ml5bwyq3imlww2h2clve/AF-B2IMY5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xFCd07EE2Dc6A020627FBe36C379d324e4f874651
First NFT owner address (bech32): 
genesis1lng8ackudgpqvflmudkr08fjfe8cw3j3pdd6c0
Current NFT ID #234401 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
234401
Accession (UniProt):
B2IMY5
Name::
tRNA dimethylallyltransferase
Experimental Method:
Predicted structure
Sequence source:
Streptococcus pneumoniae (strain CGSP14)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2IMY5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2IMY5|MIAA_STRPS tRNA dimethylallyltransferase OS=Streptococcus pneumoniae (strain CGSP14) OX=516950 GN=miaA PE=3 SV=2 MKTKIIVIVGPTAVGKTALAIEVAKRFNGEVVSGDSQQVYRGLDIGTAKASPEEQAAVPHHLIDVREITESYSAFDFVSEAKMTIEGIHNRGKLAIIAGGTGLYIQSLLEGYHLGGETPHEEILAYRASLEPYSDEELAHLVDQAGLEIPQFNRRRAMRALEIAHFGQDLENQETLYEPLIICLDDERSQLYERINHRVDLMFEAGLLDEAKWLFDHSPNVQAAKGIGYKELFPYFRGEQTLEEASESLKQATRRFAKRQLTWFRNRMQVTFYQIGESGVQDRILSQIEEFLDD